Keyphrases
Prospective Randomized Trial
100%
Erythropoietin
100%
Randomized Double-blind Study
100%
Cancer Patients
40%
Blood Transfusion
40%
RhEPO
40%
In Cancer
20%
Placebo
20%
Favorable Outcome
20%
1-year Survival
20%
Gastrointestinal Tract
20%
Malignancy
20%
Postoperative Complications
20%
Erythropoiesis
20%
Transfusion
20%
Placebo-controlled Study
20%
Allogeneic Blood Transfusion
20%
High Haematocrit
20%
Hemoglobin Concentration
20%
Reticulocyte Count
20%
Mild Anaemia
20%
Iron Control
20%
Hemoglobin Count
20%
Medicine and Dentistry
Erythropoietin
100%
Gastrointestinal Cancer
100%
Blood Transfusion
60%
Malignant Neoplasm
40%
Iron
40%
Recombinant Erythropoietin
40%
Placebo
20%
Postoperative Complication
20%
Anemia
20%
Hematocrit
20%
Cancer
20%
Gastrointestinal Tract
20%
Erythropoiesis
20%
Placebo-Controlled Study
20%
Body Weight
20%
Reticulocyte
20%
Hemoglobin Determination
20%
Pharmacology, Toxicology and Pharmaceutical Science
Erythropoietin
100%
Digestive System Cancer
100%
Malignant Neoplasm
40%
Iron
40%
Recombinant Erythropoietin
40%
Placebo
20%
Anemia
20%
Placebo-Controlled Study
20%
Postoperative Complication
20%